Clinica Baviera (MC:CBAV) — Market Cap & Net Worth
Market Cap & Net Worth: Clinica Baviera (CBAV)
Clinica Baviera (MC:CBAV) has a market capitalization of $842.36 Million (€720.51 Million) as of May 7, 2026. Listed on the MC stock exchange, this Spain-based company holds position #9968 globally and #69 in its home market, demonstrating a 6.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clinica Baviera's stock price €56.20 by its total outstanding shares 16014366 (16.01 Million). Analyse cash flow conversion of Clinica Baviera to see how efficiently the company converts income to cash.
Clinica Baviera Market Cap History: 2015 to 2026
Clinica Baviera's market capitalization history from 2015 to 2026. Data shows growth from $77.85 Million to $1.05 Billion (27.67% CAGR).
Clinica Baviera Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clinica Baviera's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.22x
Clinica Baviera's market cap is 2.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.53x
Clinica Baviera's market cap is 14.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $77.85 Million | $85.53 Million | $4.84 Million | 0.91x | 16.09x |
| 2016 | $140.20 Million | $91.57 Million | $7.94 Million | 1.53x | 17.65x |
| 2017 | $129.73 Million | $99.88 Million | $9.88 Million | 1.30x | 13.14x |
| 2018 | $208.32 Million | $109.29 Million | $11.91 Million | 1.91x | 17.49x |
| 2019 | $227.14 Million | $124.33 Million | $12.90 Million | 1.83x | 17.61x |
| 2020 | $223.96 Million | $122.63 Million | $14.13 Million | 1.83x | 15.85x |
| 2021 | $354.26 Million | $172.73 Million | $27.93 Million | 2.05x | 12.68x |
| 2022 | $302.93 Million | $198.45 Million | $30.15 Million | 1.53x | 10.05x |
| 2023 | $413.45 Million | $224.92 Million | $36.75 Million | 1.84x | 11.25x |
| 2024 | $584.14 Million | $262.65 Million | $40.20 Million | 2.22x | 14.53x |
Competitor Companies of CBAV by Market Capitalization
Companies near Clinica Baviera in the global market cap rankings as of May 7, 2026.
Key companies related to Clinica Baviera by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #121 globally with a market cap of $177.69 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #191 globally with a market cap of $123.55 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #566 globally with a market cap of $46.25 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #653 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #121 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.69 Billion | $472.95 |
| #191 | Danaher Corporation | NYSE:DHR | $123.55 Billion | $174.92 |
| #566 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.25 Billion | $579.23 |
| #653 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Clinica Baviera Historical Marketcap From 2015 to 2026
Between 2015 and today, Clinica Baviera's market cap moved from $77.85 Million to $ 1.05 Billion, with a yearly change of 27.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.05 Billion | +13.08% |
| 2025 | €930.51 Million | +59.29% |
| 2024 | €584.14 Million | +41.28% |
| 2023 | €413.45 Million | +36.48% |
| 2022 | €302.93 Million | -14.49% |
| 2021 | €354.26 Million | +58.18% |
| 2020 | €223.96 Million | -1.40% |
| 2019 | €227.14 Million | +9.03% |
| 2018 | €208.32 Million | +60.59% |
| 2017 | €129.73 Million | -7.47% |
| 2016 | €140.20 Million | +80.09% |
| 2015 | €77.85 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Clinica Baviera was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $842.36 Million USD |
| MoneyControl | $842.36 Million USD |
| MarketWatch | $842.36 Million USD |
| marketcap.company | $842.36 Million USD |
| Reuters | $842.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Clinica Baviera
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmol… Read more